|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 112, Issue 19 3361-3371, Copyright © 1999 by Company of Biologists
JOURNAL ARTICLES |
NJ Wells, N Watanabe, T Tokusumi, W Jiang, MA Verdecia and T Hunter
Molecular Biology and Virology Laboratory, The Salk Institute, La Jolla, California 92037, USA.
Activation of Cdc2, is the universal event controlling the onset of mitosis. In higher eukaryotes, Cdc2 activity is in part regulated by inhibitory phosphorylation of Thr14 and Tyr15, catalyzed by Wee1 and Myt1, which prevents catastrophic premature entry into mitosis. In this study we defined the function of Myt1 by overexpression studies in both S. pombe and a human osteosarcoma cell line. Similar to Wee1, overexpression of human Myt1 prevented entry into mitosis in both cell types; however, Myt1 catalytic activity was not essential for the cell cycle delay observed with human cells. Myt1 expression was restricted to proliferating cells. Furthermore, we detected no major decline in Myt1 protein abundance prior to the entry into mitosis, which coincides with the loss of Myt1 activity. We localized mitotic phosphoepitopes, recognized by the monoclonal antibody MPM-2, to the C-terminal domain of Myt1. The mitotic peptidyl-prolyl isomerase, Pin1, was able to associate with this domain in a phosphorylation-dependent manner. Truncation of the C-terminal domain of Myt1 prevented its ability to induce G(2)/M phase arrest in overexpression studies in human cells and dramatically reduced its ability to phosphorylate Cdc2 in vitro. We demonstrate that the C-terminal domain of Myt1 was required for recruitment of Cdc2, and we infer that this domain lies in the cytoplasm because it can interact with and is phosphorylated by Cdc2. In conclusion, we propose that Myt1 can negatively regulate Cdc2/cyclin B1 and inhibit G(2)/M progression by two means, both of which require the C-terminal domain; first, Myt1 can bind and sequester Cdc2/cyclin B1 in the cytoplasm preventing entry into the nucleus, and, second, it can phosphorylate associated Cdc2/cyclin B1 at Thr14 and Tyr15 thus inhibiting its catalytic activity.
This article has been cited by other articles:
![]() |
H. S. Choi, A. M. Bode, J.-H. Shim, S.-Y. Lee, and Z. Dong c-Jun N-Terminal Kinase 1 Phosphorylates Myt1 To Prevent UVA-Induced Skin Cancer Mol. Cell. Biol., April 15, 2009; 29(8): 2168 - 2180. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Jin, E. Homola, S. Tiong, and S. D. Campbell Drosophila Myt1 Is the Major Cdk1 Inhibitory Kinase for Wing Imaginal Disc Development Genetics, December 1, 2008; 180(4): 2123 - 2133. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nakajima, S. Yonemura, M. Murata, N. Nakamura, H. Piwnica-Worms, and E. Nishida Myt1 protein kinase is essential for Golgi and ER assembly during mitotic exit J. Cell Biol., April 3, 2008; 181(1): 89 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Seidl, M. Port, K.-P. Gilbertz, A. Morgenstern, F. Bruchertseifer, M. Schwaiger, B. Roper, R. Senekowitsch-Schmidtke, and M. Abend 213Bi-induced death of HSC45-M2 gastric cancer cells is characterized by G2 arrest and up-regulation of genes known to prevent apoptosis but induce necrosis and mitotic catastrophe Mol. Cancer Ther., August 1, 2007; 6(8): 2346 - 2359. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Bryan, O. F. Dyson, and S. M. Akula Identifying cellular genes crucial for the reactivation of Kaposi's sarcoma-associated herpesvirus latency. J. Gen. Virol., March 1, 2006; 87(Pt 3): 519 - 529. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Jin, E. M. Homola, P. Goldbach, Y. Choi, J. A. Brill, and S. D. Campbell Drosophila Myt1 is a Cdk1 inhibitory kinase that regulates multiple aspects of cell cycle behavior during gametogenesis Development, September 15, 2005; 132(18): 4075 - 4085. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.-M. Kim, S. Ramakrishna, G. A. Gusarova, H. M. Yoder, R. H. Costa, and V. V. Kalinichenko The Forkhead Box M1 Transcription Factor Is Essential for Embryonic Development of Pulmonary Vasculature J. Biol. Chem., June 10, 2005; 280(23): 22278 - 22286. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-C. Goulet, M. Chigbrow, P. Frisk, and M. A. Nelson Selenomethionine induces sustained ERK phosphorylation leading to cell-cycle arrest in human colon cancer cells Carcinogenesis, January 1, 2005; 26(1): 109 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chen and D. G. Gardner Suppression of WEE1 and Stimulation of CDC25A Correlates with Endothelin-dependent Proliferation of Rat Aortic Smooth Muscle Cells J. Biol. Chem., April 2, 2004; 279(14): 13755 - 13763. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Major, R. Lepe, and R. H. Costa Forkhead Box M1B Transcriptional Activity Requires Binding of Cdk-Cyclin Complexes for Phosphorylation-Dependent Recruitment of p300/CBP Coactivators Mol. Cell. Biol., April 1, 2004; 24(7): 2649 - 2661. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Watanabe, H. Arai, Y. Nishihara, M. Taniguchi, N. Watanabe, T. Hunter, and H. Osada M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCF{beta}-TrCP PNAS, March 30, 2004; 101(13): 4419 - 4424. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Sanchez, A. K. McElroy, and D. H. Spector Mechanisms Governing Maintenance of Cdk1/Cyclin B1 Kinase Activity in Cells Infected with Human Cytomegalovirus J. Virol., December 15, 2003; 77(24): 13214 - 13224. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. H. Chow, W. Y. Siu, H. T. B. Ho, K. H. T. Ma, C. C. Ho, and R. Y. C. Poon Differential Contribution of Inhibitory Phosphorylation of CDC2 and CDK2 for Unperturbed Cell Cycle Control and DNA Integrity Checkpoints J. Biol. Chem., October 17, 2003; 278(42): 40815 - 40828. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Passer, V. Nancy-Portebois, N. Amzallag, S. Prieur, C. Cans, A. Roborel de Climens, G. Fiucci, V. Bouvard, M. Tuynder, L. Susini, et al. The p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase PNAS, March 4, 2003; 100(5): 2284 - 2289. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ryo, Y.-C. Liou, K. P. Lu, and G. Wulf Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer J. Cell Sci., March 1, 2003; 116(5): 773 - 783. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-k. Huang, S. L. Forsburg, U. P. John, M. J. O'Connell, and T. Hunter Isolation and characterization of the Pin1/Ess1p homologue in Schizosaccharomyces pombe J. Cell Sci., March 12, 2002; 114(20): 3779 - 3788. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Lamitina and S. W. L'Hernault Dominant mutations in the Caenorhabditis elegans Myt1 ortholog wee-1.3 reveal a novel domain that controls M-phase entry during spermatogenesis Development, January 11, 2002; 129(21): 5009 - 5018. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Rothblum-Oviatt, C. E. Ryan, and H. Piwnica-Worms 14-3-3 Binding Regulates Catalytic Activity of Human Wee1 Kinase Cell Growth Differ., December 1, 2001; 12(12): 581 - 589. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Thorpe, S. J. Morley, and S. L. Rulten Utilizing the Peptidyl-Prolyl Cis-Trans Isomerase Pin1 as a Probe of Its Phosphorylated Target Proteins: Examples of Binding to Nuclear Proteins in a Human Kidney Cell Line and to Tau in Alzheimer's Diseased Brain J. Histochem. Cytochem., January 1, 2001; 49(1): 97 - 108. [Abstract] [Full Text] |
||||